A summary of studies reporting the rate of IPC-related pleural infection (in chronological order)
| Number of IPCs | Reported rate of pleural infection (%) | Other comments | |
|---|---|---|---|
| Putnam et al35 | 100 | 5 | MPE |
| Van den Toorn et al36 | 17 | 12 | MPE |
| Murthy et al37 | 63 | 1.7 | MPE (83%) |
| Tremblay et al9 | 250 | 3.2 | MPE |
| Warren et al22 | 231 | 2.2 | MPE |
| Sioris et al38 | 51 | 5.8 | MPE |
| Morel et al32* | 82 | 9 | MPE |
| Bertolaccini et al39 | 90 | 0 | MPE |
| Davies et al7 | 52 | 9.6 | MPE |
| Hunt et al40 | 59 | 1.7 | MPE |
| Fysh et al12 | 34 | 10.8 | MPE |
| Mekhaiel et al31† | 262 | 6.1 | MPE |
| Srour et al17 | 43 | 0 | Cardiac effusions |
| Bhatnagar et al16 | 57 | 3.5 | Benign effusions |
| Ost et al21 | 266 | 1 | MPE |
| Rial et al41 | 50 | 3.6 | MPE |
| Bibby et al28 | 672 | 3.7 | MPE |
| Gilbert et al34 | 225 | 5.8 | MPE |
| Gilbert et al30 | 91 | 7.7 (2.2% mortality) | MPE from haematological malignancies |
*Twenty-three patients in this study received chemotherapy with IPC in situ; no difference in infection rate.
†The overall infection rate was 6.1%, which included 5.2% from those who received chemotherapy and 7.9% from the non-chemotherapy group.
IPC, indwelling pleural catheter; MPE, malignant pleural effusion.